MiMedx Group, Inc. (MDXG)
4.43
-0.25
(-5.34%)
USD |
NASDAQ |
Oct 16, 16:00
4.435
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Cash from Investing (Quarterly) : -0.635M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.635M |
| March 31, 2026 | -5.642M |
| December 31, 2025 | -0.335M |
| September 30, 2025 | -5.258M |
| June 30, 2025 | -0.887M |
| March 31, 2025 | -0.406M |
| December 31, 2024 | -2.767M |
| September 30, 2024 | 0.113M |
| June 30, 2024 | -0.905M |
| March 31, 2024 | -6.024M |
| December 31, 2023 | -0.481M |
| September 30, 2023 | -0.649M |
| June 30, 2023 | -0.348M |
| March 31, 2023 | -0.677M |
| December 31, 2022 | -1.709M |
| September 30, 2022 | -0.374M |
| June 30, 2022 | -0.429M |
| March 31, 2022 | -0.148M |
| December 31, 2021 | -0.314M |
| September 30, 2021 | -0.58M |
| June 30, 2021 | -0.422M |
| March 31, 2021 | -2.079M |
| December 31, 2020 | -2.273M |
| September 30, 2020 | -0.71M |
| June 30, 2020 | -0.486M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.086M |
| December 31, 2019 | -0.793M |
| September 30, 2019 | 2.06M |
| June 30, 2019 | -0.33M |
| March 31, 2019 | -0.433M |
| December 31, 2018 | -1.186M |
| September 30, 2018 | -2.453M |
| June 30, 2018 | -2.474M |
| March 31, 2018 | -3.107M |
| December 31, 2017 | -1.255M |
| September 30, 2017 | -1.394M |
| June 30, 2017 | -1.779M |
| March 31, 2017 | -0.969M |
| December 31, 2016 | -1.295M |
| September 30, 2016 | -1.734M |
| June 30, 2016 | 0.573M |
| March 31, 2016 | -9.286M |
| December 31, 2015 | 1.592M |
| September 30, 2015 | -1.105M |
| June 30, 2015 | -0.117M |
| March 31, 2015 | -1.048M |
| December 31, 2014 | -9.845M |
| September 30, 2014 | -0.8732M |
| June 30, 2014 | -0.8004M |
| March 31, 2014 | -0.6337M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | -1.28M |
| Perspective Therapeutics, Inc. | 15.02M |
| ABVC BioPharma, Inc. | -0.1015M |
| Enovis Corp. | -45.01M |
| Edwards Lifesciences Corp. | -193.20M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -10.03M |
| Cash from Financing (Quarterly) | -13.27M |
| Free Cash Flow | 42.33M |
| Free Cash Flow Per Share (Quarterly) | -0.0722 |
| Free Cash Flow to Equity (Quarterly) | -10.28M |
| Free Cash Flow to Firm (Quarterly) | -10.34M |
| Free Cash Flow Yield | 6.41% |